Table 5 Immunohistochemistry findings in UESL cases. +++: strong staining intensity; ++: moderate staining intensity; +: weak staining intensity; f: focal staining
| Â | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 8 |
|---|---|---|---|---|---|---|---|
Vimentin | +++ | +++f | – | +++ | +++ | +++ | +++ |
HepPar1 | – | – | – | – | – | – | – |
Glypican 3 | +++f | +++f | ++ | +++ | +++ | ++f | ++ |
Arginase-1 | – | – | – | – | – | – | – |
Desmin | +++ | +++f | +f | +++f | +++ | +++f | +++ |
SMA | – | +++f | – | +++f | + | +++f | +++f |
CD56 | +++ | +++ | +++ | ++ | +++ | +++ | +++ |
CD10 | ++ | +++ | +++ | ++f | +++ | – | + |
CD68 | – | – | – | +++ | – | +++f | – |
BCL2 | +++ | – | + | + | + | +++ | + |
PD-L1 | – | – | – | – | – | – | – |
C-Kit | – | +++f | – | – | – | – | +f |
CD34 | – | – | – | – | – | – | – |
Ki67 | 80% | 40% | 15% | 80% | 60% | 15% | 90% |